Literature DB >> 28327365

Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?

Poonam Mishra1, Minjun Chen2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28327365     DOI: 10.1053/j.gastro.2017.03.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

Review 1.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

2.  Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.

Authors:  Raymond S Koff
Journal:  Am J Gastroenterol       Date:  2017-09       Impact factor: 10.864

3.  Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.

Authors:  Xinyi Jiang; Scott Martin Vouri; Vakaramoko Diaby; Weihsuan Lo-Ciganic; Robert Parker; Haesuk Park
Journal:  J Manag Care Spec Pharm       Date:  2021-10

Review 4.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

5.  The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity.

Authors:  Jieqiang Zhu; Ji-Eun Seo; Sanlong Wang; Kristin Ashby; Rodney Ballard; Dianke Yu; Baitang Ning; Rajiv Agarwal; Jürgen Borlak; Weida Tong; Minjun Chen
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

6.  Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.

Authors:  Milo Gatti; Elisabetta Poluzzi; Fabrizio De Ponti; Emanuel Raschi
Journal:  Drug Saf       Date:  2020-12       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.